Stocks in Focus

CJ CGV Soars 13% on News of Investment by the National Growth Fund

Kim Kyung-eun
2026-07-30 09:21:04
[Edaily Reporter Kim Kyung-eun ] Shares of CJ CGV(079160)are trading higher in early trading on the 30th following news that the company is receiving an investment from the National Growth Fund.

(Photo = News1)


According to MP Doctor, as of 9:15 a.m. today, CJ CGV is trading at 5,390 won, up 620 won (13.00%) from the previous trading day.

This is interpreted as a result of media reports that CJ 4Dplex, a subsidiary of CJ CGV, is set to receive a large-scale investment from the National Growth Fund, which has boosted investor sentiment.

According to the reports, CJ Corp. 4Dplex is seeking to attract 200 billion won in external investment, and the National Growth Fund is considering a plan to invest by matching funds from the High-Tech Strategic Industry Fund with private capital.

The National Growth Fund is a policy-driven growth fund that will be established with a total scale of 200 trillion won over the next five years. It pools funds from the government and private financial institutions to invest in high-tech industries—such as semiconductors, artificial intelligence (AI), and biotechnology—and related companies.

Economy

Corporation

IT·Science

Economy

"Aftermath of the Jensen Huang Scandal… U.S. to Impose Strict Export Controls on China"

“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
2026-11-13 17:31:12

Corporation

HITEJINRO Enters the Soju-Beer Mix Cans Market… Remarks by Cho Woong-rae, Chairman of Shenyang Soju

“I hear that a major conglomerate is set to launch a soju-beer mix can—a blend of Terra Beer and Chamisul—in the soju-beer can market that we’ve worked so hard to pioneer.”This is a handwritten post t…
2026-11-13 19:38:55

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02